ASH Clinical News ACN_4.6_Full_Issue_web

DEEPEN YOUR KNOWLEDGE OF FLT3m+ AML AT BOOTH #18005 Go to FLT3-AML.com AML=acute myeloid leukemia; FLT3=FMS-like tyrosine kinase 3; m+=mutation positive. © 2018 Astellas Pharma US, Inc. All rights reserved. 077-0151-PM. 04/18 Printed in USA. Astellas and the flying star logo are trademarks of Astellas Pharma Inc.